ARTICLE | Company News
Curis licenses Aegera's stem cell technology
January 8, 2001 8:00 AM UTC
Aegera (Montreal, Quebec) granted CRIS an exclusive worldwide license to its skin-derived, adult stem cell technologies for developing therapeutics to treat neurological, pancreatic and cardiovascular...